Literature DB >> 8975378

[Minimally invasive osteosynthesis of fractures of the tibial head].

P Lobenhoffer1, M Schulze, H Tscherne.   

Abstract

The role of closed reduction techniques in tibial plateau fractures was evaluated retrospectively in a group of 33 patients. The patients had mainly B fractures (AO classification) and were treated by the arthroscopic reduction technique (n = 10) or by reduction under fluoroscopic control (n = 23) and transcutaneous screw fixation. The 21 patients with an average follow-up of 34 months (minimum 1 year) were reviewed. Using clinical and radiological criteria, 19 results were considered excellent to good. One patient with a residual deformity was revised with a total knee and 1 patient with an anatomical result had arthritic pain in the knee operated on. Arthroscopic reduction had no advantages over reduction under fluoroscopic control in this study. The specific value of the technically demanding endoscopic procedure should be questioned, as percutaneous reduction under fluoroscopic control may achieve comparable results in the majority of these cases.

Entities:  

Mesh:

Year:  1996        PMID: 8975378

Source DB:  PubMed          Journal:  Unfallchirurg        ISSN: 0177-5537            Impact factor:   1.000


  4 in total

1.  [Not Available].

Authors:  H Tscherne; P Lobenhoffer
Journal:  Oper Orthop Traumatol       Date:  1998-09       Impact factor: 1.154

2.  [Minimally invasive treatment of monocondylar tibial plateau fractures. Percutaneous reduction and small fragment osteosynthesis].

Authors:  M Walz; F Auerbach; B Kolbow; T Junker
Journal:  Unfallchirurg       Date:  2006-05       Impact factor: 1.000

3.  [Use of the injectable bone cement Norian SRS for tibial plateau fractures. Results of a prospective 30-month follow-up study].

Authors:  A Jubel; J Andermahr; J Mairhofer; A Prokop; U Hahn; K E Rehm
Journal:  Orthopade       Date:  2004-08       Impact factor: 1.087

Review 4.  [Fracture of the tibial head].

Authors:  W Petersen; T Zantop; M Raschke
Journal:  Unfallchirurg       Date:  2006-03       Impact factor: 1.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.